Psychopharmacology — Department of Psychiatry

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Groups within this theme

The Brain Informatics Group was launched at the University of Oxford with a mission to improve brain health by building advanced data science techniques and applying them to large-scale multimodal data, with a particular focus on international health records datasets.

The Brain Informatics Group

People with mental illness have a markedly shorter life expectancy than the general population, largely because of preventable cardiometabolic disease. We are interested in understanding this not simply as a comorbidity, but as part of the biology of these conditions, from the early, at-risk stages through to chronic severe mental illness.

Metabolic Brain and Body

Understanding Psychosis Across Brain, Behaviour, & Treatment

OPERA (Oxford Psychosis: Research & Application)

Our work combines cognitive neuroscience, applied clinical psychology and pharmacology to investigate the basic mechanisms of CBT and psychopharmacological treatments to find out what exactly it is that makes patients get better.

OXITED - Oxford Improving Treatment for Emotional Disorders

We explore how the brain processes emotional information and how this is influenced by brain chemicals and medicines. This helps us to understand disorders such as depression and anxiety and to understand and contribute to the development of drug and psychological treatments.

Psychopharmacology and Emotion Research Laboratory (PERL)

Principal Investigators

Philip Cowen

Professor of Psychopharmacology

Catherine Harmer

Associate Head of Department (People and Culture), Professor of Cognitive ...

Susannah Murphy

Director of Graduate Studies Associate Professor

John Geddes

Professor of Psychiatry